StonvexLoading…
StonvexCore line items from LLYVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $381.95M | $340.49M |
Operating Income | $-51.73M | $-116.27M |
Net Income | $-86.97M | $-112.76M |
EPS (Diluted) | Not available | Not available |
Total Assets | $1.89B | $1.59B |
Total Liabilities | $1.92B | $1.76B |
Cash & Equivalents | $545.49M | $402.64M |
Free Cash Flow OCF − CapEx | Not available | Not available |
Shares Outstanding | 92.47M | Not available |